These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9248897)

  • 1. Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil--an area of Leishmania (V.) braziliensis transmission.
    Oliveira-Neto MP; Schubach A; Mattos M; da Costa SC; Pirmez C
    Int J Dermatol; 1997 Jun; 36(6):463-8. PubMed ID: 9248897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years).
    Oliveira-Neto MP; Schubach A; Mattos M; Goncalves-Costa SC; Pirmez C
    Am J Trop Med Hyg; 1997 Dec; 57(6):651-5. PubMed ID: 9430521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens.
    Oliveira-Neto MP; Schubach A; Mattos M; Gonçalves-Costa SC; Pirmez C
    Pathol Biol (Paris); 1997 Jun; 45(6):496-9. PubMed ID: 9309267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
    Bogenrieder T; Lehn N; Landthaler M; Stolz W
    Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methylglucamine antimonate (SbV+): intralesional canine tegumentary leishmaniasis therapy.
    Barbosa Santos EG; Marzochi MC; Conceição NF; Brito CM; Barroso JA; Pacheco RS
    Parasite; 1998 Jun; 5(2):175-80. PubMed ID: 9754314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated American cutaneous leishmaniasis.
    Bonfante-Garrido R; Barroeta S; de Alejos MA; Meléndez E; Torrealba J; Valdivia O; Momen H; Grimaldi Júnior G
    Int J Dermatol; 1996 Aug; 35(8):561-5. PubMed ID: 8854152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.
    Netto EM; Marsden PD; Llanos-Cuentas EA; Costa JM; Cuba CC; Barreto AC; Badaró R; Johnson WD; Jones TC
    Trans R Soc Trop Med Hyg; 1990; 84(3):367-70. PubMed ID: 2260171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
    Brito NC; Rabello A; Cota GF
    PLoS One; 2017; 12(9):e0184777. PubMed ID: 28926630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.
    Silva SC; Guimarães LH; Silva JA; Magalhães V; Medina L; Queiroz A; Machado PRL; Schriefer A
    Acta Trop; 2018 Feb; 178():34-39. PubMed ID: 29042262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy].
    Yeşilova Y; Turan E; Sürücü HA; Aksoy M; Özbilgin A
    Turkiye Parazitol Derg; 2015 Mar; 39(1):63-5. PubMed ID: 25917587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial.
    Prates FV; Dourado ME; Silva SC; Schriefer A; Guimarães LH; Brito MD; Almeida J; Carvalho EM; Machado PR
    Clin Infect Dis; 2017 Jan; 64(1):67-71. PubMed ID: 27803094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.
    Machado PRL; Prates FVO; Boaventura V; Lago T; Guimarães LH; Schriefer A; Corte TWF; Penna G; Barral A; Barral-Netto M; Carvalho EM
    Clin Infect Dis; 2021 Oct; 73(7):e2465-e2469. PubMed ID: 32894278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of New World cutaneous and mucosal leishmaniases.
    Berman JD
    Clin Dermatol; 1996; 14(5):519-22. PubMed ID: 8889330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. South American cutaneous leishmaniasis of the eyelids: report of five cases in Rio de Janeiro State, Brazil.
    Oliveira-Neto MP; Martins VJ; Mattos MS; Pirmez C; Brahin LR; Benchimol E
    Ophthalmology; 2000 Jan; 107(1):169-72. PubMed ID: 10647737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
    Gagini T; de Oliveira Schubach A; de Fatima Madeira M; Maria Valete-Rosalino C; Fernandes Pimentel MI; da Silva Pacheco R
    Parasite; 2017; 24():34. PubMed ID: 28959938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High and low doses of antimony (Sbv) in American cutaneous leishmaniasis. A five years follow-up study of 15 patients.
    Oliveira Neto MP; Schubach A; Araujo ML; Pirmez C
    Mem Inst Oswaldo Cruz; 1996; 91(2):207-9. PubMed ID: 8736092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
    Carvalho SH; Frézard F; Pereira NP; Moura AS; Ramos LMQC; Carvalho GB; Rocha MOC
    Trop Med Int Health; 2019 Apr; 24(4):380-391. PubMed ID: 30681239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis.
    Brito G; Dourado M; Guimarães LH; Meireles E; Schriefer A; de Carvalho EM; Machado PRL
    Am J Trop Med Hyg; 2017 May; 96(5):1155-1159. PubMed ID: 28500815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S; Marr JJ
    N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.